Bicycle Therapeutics PLC BCYC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/21/24 EDT
21.60UNCH (UNCH)
Volume
198,912
52 week range
12.54 - 28.91
Loading...
  • Open21.62
  • Day High21.94
  • Day Low20.99
  • Prev Close21.60
  • 52 Week High28.91
  • 52 Week High Date06/20/23
  • 52 Week Low12.54
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap924.027M
  • Shares Out42.78M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change19.47

KEY STATS

  • Open21.62
  • Day High21.94
  • Day Low20.99
  • Prev Close21.60
  • 52 Week High28.91
  • 52 Week High Date06/20/23
  • 52 Week Low12.54
  • 52 Week Low Date11/13/23
  • Market Cap924.027M
  • Shares Out42.78M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change19.47

RATIOS/PROFITABILITY

  • EPS (TTM)-4.45
  • P/E (TTM)-4.85
  • Fwd P/E (NTM)-4.30
  • EBITDA (TTM)-173.09M
  • ROE (TTM)-56.13%
  • Revenue (TTM)41.61M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-404.14%
  • Debt To Equity (MRQ)8.65%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bicycle Therapeutics PLC

 

Profile

MORE
Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. The Company is evaluating BT8009, a Bicycle Toxin Conjugate (BTC) targeting Nectin-4, a...
Pierre Legault
Non-Executive Chairman of the Board
Kevin Lee Ph.D.
Chief Executive Officer, Executive Director
Alistair Milnes
Chief Operating Officer
Alethia Young M.D.
Chief Financial Officer, Principal Financial Officer
Michael Skynner Ph.D.
Chief Technology Officer
Travis Thompson
Chief Accounting Officer, Principal Accounting Officer
Address
Blocks A & B, Portway Building, Granta P
Cambridge
CB21 6GS
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
ZNTL
Zentalis Pharmaceuticals Inc
11.58UNCHUNCH
RLAY
Relay Therapeutics Inc
7.56UNCHUNCH
TNGX
Tango Therapeutics Inc
7.47UNCHUNCH
CVAC
CureVac NV
3.29UNCHUNCH
LQDA
Liquidia Corp
13.25UNCHUNCH